Exploring immune-related pathogenesis in lung injury: Providing new insights Into ALI/ARDS
Top Cited Papers
Open Access
- 21 May 2024
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 175, 116773
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Targeting immunometabolism against acute lung injuryClinical Immunology, 2023
- Role of Toll‐like receptors in the pathogenesis of COVID‐19Journal of Medical Virology, 2021
- Is a “Cytokine Storm” Relevant to COVID-19?JAMA Internal Medicine, 2020
- Acute lung injuryCurrent Problems in Surgery, 2020
- Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathwaysInternational Immunopharmacology, 2015
- Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathwayInternational Immunopharmacology, 2015
- Danger‐associated molecular patterns (DAMPs) in acute lung injuryThe Journal of Pathology, 2012
- Suppression of MAPK and NF-κB Pathways by Limonene Contributes to Attenuation of Lipopolysaccharide-Induced Inflammatory Responses in Acute Lung InjuryInflammation, 2012
- Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in miceInternational Immunopharmacology, 2012
- A 12-month clinical survey of incidence and outcome of acute respiratory distress syndrome in Shanghai intensive care unitsIntensive Care Medicine, 2004